Census of physical disabilities caused by leprosy during and after drug discharge in state of São Paulo, Brazil
DOI:
https://doi.org/10.47456/rbps.v25i3.42013Keywords:
Prevalence, Disabilities, Leprosy, Disability Assessment, Disabled PersonAbstract
Introduction: The prevention, monitoring and treatment of physical disabilities caused by leprosy is a challenge for endemic countries. Objective: The objective was to verify the prevalence and describe the physical disabilities caused by leprosy in the eyes, nose, hands and feet through the Census of Disabilities of the State of São Paulo (CIESP) of 67 municipalities in the years 2012 and 2015. Patients undergoing treatment were eligible and those with chemotherapy discharge. Methods: The forms were audited and then analyzed by EPI INFO 7.2. Results: Of the 724 forms evaluated, 456 (63%) had one to four physical deficiencies already installed in the eyes, nose, hands and feet. The most affected segments were feet 265 (36.6%) followed by hands 163 (22.5%), eyes 110 (15.2%) and nose 45 (6.2%). The occurrence of disabilities was found in 91.1% (51/56) municipalities and the average was four cases per municipality (minimum 1 and maximum 7). Conclusion: Despite being a region of low endemicity, six out of ten individuals have physical disabilities in different body segments with a variety of conditions. It is concluded that a serious problem must be addressed by managers, health professionals and the population.
Downloads
References
De Santana EMF, de Brito KKG, Nogueira J de A, Leadebal ODCP, Costa MML, da Silva MA, Soares MJGO. Deficiências e incapacidades na hanseníase: do diagnóstico à alta por cura. Rev. Eletr. Enferm. [Internet]. 2018 Aug 27 [cited ]; 200.
Santos DFD, Mendonça MR, Antunes DE, Sabino EFD, Pereira RC, Goulart LR, Goulart IMB. Revisiting primary neural leprosy: Clinical, serological, molecular, and neuro physiological aspects. PLoS neglected tropical diseases. 2017 Nov 27; 11(11):e0006086.
Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. Guia prático sobre a hanseníase [recurso eletrônico] / Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância das Doenças Transmissíveis. Brasília: Ministério da Saúde; 2017.
World Health Organization. Regional Office for South-East Asia. Guidelines for the diagnosis, treatment and prevention of leprosy. [s. l.]: World Health Organization, Regional Office for South-East Asia; 2018.
Silva JSR, Palmeira IP, Sá AMM, Nogueira LMV, Ferreira AMR. Variáveis clínicas associadas ao grau de incapacidade física na hanseníase. Rev Cuid. 2019; 10(1):e618.
Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica: Manual de preven¬ção de incapacidades. 3.ed. Brasília: Ministério da Saúde; 2008.
Sanchez MN, Nery JS, Pescarini JM, Mendes AA, Ichihara MY, Teixeira CSS, Penna MLF, Smeeth L, Rodrigues LC, Barreto ML, Brickley EB, Penna GO. Physical disabilities caused by leprosy in 100 million cohort in Brazil. BMC Infect Dis. 2021 Mar 22; 21(1):290.
Rodrigues JC, Santos DL, Palmares G, Oliveira ER, Reis FJJ, Gomes MK. The correlation between working capacity, activity limitations and social participation restrictions among people affected by leprosy. Lepr Rev. 2017; 88:391-398.
World Health Organization, Regional Office for South-East Asia. Global Leprosy Strategy 2016–2020: Accelerating towards a leprosy-free world. WHO Regional Office for South-East Asia: WHO; 2016.
São Paulo. Centro de Vigilância Epidemiológica (CVE). Casos Novos, Coeficiente de Detecção, Prevalência e Coeficiente de Prevalência de Hanseníase distribuídos por GVE/ Município de Residência. Estado de S. Paulo; 2018-2019.
São Paulo. Secretaria de Estado da Saúde. Direção Regional De Saúde. São José Do Rio Preto – DIR XXII. Vigilância Epide¬miológica. Projeto Estadual de Promoção de Saúde. São Paulo: DCNT; 2010.
Nardi SMT, Medalha MF, Ferreira ER, Marzliak, MLC, Lafratta TE, da Costa MHV, Pedro HSP, Paschoal VDA. Censo de Incapacidades do Estado de São Paulo/2012: Importante Ferramenta para Identi¬ficar as necessidades individuais das pessoas que tem ou tiveram Hanseníase [Resumo]. Hansen Int. 2013; 38(Supl 1):136.
Marzliak MLC. Censo de Incapacidades por Hanseníase, Estado de São Paulo, 2015 [Resumo]. Hansen Int. 2017; 42(Suppl 1):159.
CIF: Classificação Internacional de Funcionalidade, Incapaci¬dade e Saúde. 1.ed., 3. reimpr. atual. São Paulo: Editora da Uni¬versidade de São Paulo; 2020.
Tabela 6579 - População residente estimada. IBGE – Estimativas de População; 2021 [cited 2023 Dec 14]. Available from: https://sidra.ibge.gov.br/tabela/6579#resultado
Bernardes Filho F, de Paula NA, Leite MN, Abi-Rached TLC, Vernal S, Silva MB da et al. Evidence of hidden leprosy in a supposedly low endemic area of Brazil. Mem. Inst. Oswaldo Cruz. 2017 Dec; 112(12):822-828.
De Paula HL, de Souza CDF, Santos VS. Risk Factors for Physi¬cal Disability in Patients With Leprosy A Systematic Review and Meta-analysis. JAMA Dermatology. 2019.
Srinivas G, Muthuvel T, Lal V, Vaikundanathan K, Schwie¬nhorst-Stich E-M, Kasang C () Risk of disability among adult leprosy cases and determinants of delay in diagnosis in five sta¬tes of India: A case-control study. PLoS Negl Trop Dis. 2019; 13(6):e0007495.
Santoshdev P, Rathod, AJ, Pooja C. Disabilities in leprosy: an open, retrospective analyses of institutional records, Anais Bra¬sileiros de Dermatologia. 2020; 95(1):52-56. ISSN 0365-0596.
Abreu C, Vilhena M, de Miranda S.T, Alexander E, da Silva M.C.D, Alves da Cunha A.J.L, Gomes M.K., Situation of the foot at risk due to leprosy in the municipality of Rio de Janeiro; Leprosy Review. 2021; 92(2):124-133.
Sanchez MN, Nery JS, Pescarini JM et al. Physical disabilities caused by leprosy in 100 million cohort in Brazil. BMC Infect Dis. 2021; 21(290).
Leano HAM, Araújo KMFA, Bueno IC, Niitsuma ENA, Lana FCF. Socioeconomic factors related to leprosy: an integrative literature review. Rev Bras Enferm. 2019; 72(5):1405-15.
Mowla MR, Angkur DM, Hasan Z, Sultana MN, Afrin S, Akh¬ter MS. Leprosy patients with deformities at post‐ elimination stage: The Bangladesh experience. Skin Health Dis. 2021; 1:e5.
Upputuri B, Srikantam A, Mamidi RS. Comorbidities associa¬ted with non- healing of plantar ulcers in leprosy patients. PLOS Negl Trop Dis. 2020; 14(6):e0008393.
Borela MCM, Cury Filho M, Kirchner DR, Salgado MH, Vir¬mond MCL, Garbino já. Neurophysiological comparative res¬ponse to clinical and surgical treatment of the ulnar neuropathy in leprosy. Acta Fisiatr. 2020; 27(3):125-130
Chowdhury S, Sneha, Priyanka, Harsha. Leprosy and Eye Inju¬ries. Clin Dermatol J. 2019, 4(1):000169.
Pavezzi PD, do Prado RB, Boin Filho PÂ, Gon ADS, Tuma B, Fornazieri MA, et al. Evaluation of ocular involvement in patients with Hansen’s disease. PLoS Negl Trop Dis. 2020; 14(9):e0008585.
Sun WH, Li YR, Fang TY. Leprosy manifesting as nasal obstruc¬tion and epistaxis. Journal of the Formosan Medical Associa¬tion. 2018.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Brazilian Journal of Health Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Revista Brasileira de Pesquisa em Saúde (RBPS) adopts the CC BY 4.0 license, which means that authors retain the copyright of the works they submit to the journal. Authors are responsible for declaring that their contribution is an original manuscript, that it has not been previously published, and that it is not under simultaneous review by another scientific journal. Upon submitting the manuscript, authors grant RBPS the exclusive right of first publication, subject to peer review.
Authors are permitted to enter into additional contracts for the non-exclusive distribution of the version published by RBPS (for example, in institutional repositories or as a book chapter), provided that due acknowledgment of authorship and of initial publication by RBPS is given. Authors are also encouraged to make their work available online (for example, in institutional repositories or on their personal pages) after its initial publication in the journal, with due acknowledgment of authorship and of the original publication by RBPS.
Accordingly, under the CC BY 4.0 license, readers have the right to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially;
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
